A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.
Feifei GuoOlga Estévez-VázquezRaquel Benedé-UbietoDouglas Maya-MilesKang ZhengRocío Gallego-DuránÁngela RojasJavier AmpueroManuel RomeroKaye PhilipIsioma U EgbuniweChaobo ChenJorge SimonTeresa Cardoso DelgadoMaría Luz Martínez-ChantarJie SunJohanna ReissingKaren SchmidtArantza Lamas-PazManuel Gómez Del MoralMarius Maximilian WoitokJavier VaqueroJose R RegueiroChristian LiedtkeChristian TrautweinRafael BañaresFrancisco Javier CuberoYulia A NevzorovaPublished in: Cancers (2021)
A novel function of c-MYC in MAFLD progression was identified opening new avenues for preventative strategies.